Niagen Bioscience, Inc.
NAGE
$6.50
$0.101.48%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.22% | 2.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.22% | 2.09% | |||
| Cost of Revenue | 10.72% | -2.32% | |||
| Gross Profit | 8.41% | 4.63% | |||
| SG&A Expenses | 2.73% | 16.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.51% | 8.65% | |||
| Operating Income | 33.00% | -33.26% | |||
| Income Before Tax | 28.45% | -28.56% | |||
| Income Tax Expenses | 73.44% | -23.81% | |||
| Earnings from Continuing Operations | 26.85% | -28.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 26.85% | -28.72% | |||
| EBIT | 33.00% | -33.26% | |||
| EBITDA | 31.06% | -31.93% | |||
| EPS Basic | 26.15% | -30.11% | |||
| Normalized Basic EPS | 27.46% | -29.76% | |||
| EPS Diluted | 25.00% | -33.33% | |||
| Normalized Diluted EPS | 27.68% | -31.04% | |||
| Average Basic Shares Outstanding | 0.67% | 1.85% | |||
| Average Diluted Shares Outstanding | 0.44% | 3.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||